GlobeNewswire
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date
➖
AI Sentiment
Neutral
5/10
NRX Pharmaceuticals Inc. News
Latest updates and market news for NRXP
2 news
Jan 13 - Jan 19, 2026
Page 1
GlobeNewswire
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
📈
AI Sentiment
Highly Positive
9/10
Share this news page